AbbVie: Patient-centric individualisation of treatment: Will AI introduce a paradigm shift in the treatment of retinal diseases?
Location: 212
Date & Time: Thursday, 19 September, 13:30 - 14:30 CEST
Chairperson(s): B. Kuppermann, USA
Speakers:
Presentations:
B. Kuppermann USA
13:30 Introduction and symposium objectives
J. Zarranz-Ventura SPAIN
13:35 Early individualisation of retinal disease treatment with AI
A. Couturier FRANCE
13:50 Optimising biomarkers in DME – update on clinical evidence
U. Schmidt-Erfurth AUSTRIA
14:05 Is retinal fluid the most relevant parameter in the management of retinal disease?
All Faculty
14:20 Q&A and meeting close
